Neil A. Jones

1.9k total citations
21 papers, 1.5k citations indexed

About

Neil A. Jones is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Neil A. Jones has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Neil A. Jones's work include Protease and Inhibitor Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). Neil A. Jones is often cited by papers focused on Protease and Inhibitor Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). Neil A. Jones collaborates with scholars based in United Kingdom, United States and France. Neil A. Jones's co-authors include Angela Woods, David Carling, Matt Davison, Caroline Dive, John A. Hickman, Bernard M. Corfe, Laurence Dubrez, Gareth Griffiths, Clive P. Morgan and Clive Page and has published in prestigious journals such as The Journal of Cell Biology, Biochemical Journal and FEBS Letters.

In The Last Decade

Neil A. Jones

21 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil A. Jones United Kingdom 12 1.2k 286 260 235 174 21 1.5k
Prem M. Sharma United States 18 1.2k 1.1× 230 0.8× 138 0.5× 284 1.2× 178 1.0× 26 1.6k
Winnie Eskild Norway 25 1.0k 0.9× 337 1.2× 281 1.1× 109 0.5× 201 1.2× 63 1.8k
Gabriel Gil‐Gómez Spain 19 1.4k 1.2× 130 0.5× 397 1.5× 328 1.4× 155 0.9× 34 1.9k
Chia-Chen Chen Taiwan 11 1.3k 1.1× 170 0.6× 244 0.9× 213 0.9× 198 1.1× 19 1.9k
Justina C. Wolters Netherlands 22 854 0.7× 387 1.4× 299 1.1× 192 0.8× 283 1.6× 69 1.6k
Timothy Hadden United States 10 841 0.7× 147 0.5× 209 0.8× 130 0.6× 93 0.5× 14 1.2k
Seiji Inoshita Japan 19 1.0k 0.9× 178 0.6× 184 0.7× 80 0.3× 80 0.5× 38 1.5k
Lihong Chen China 20 1.1k 1.0× 143 0.5× 478 1.8× 245 1.0× 186 1.1× 50 1.7k
Yosuke Kawase Japan 19 931 0.8× 165 0.6× 188 0.7× 140 0.6× 139 0.8× 33 1.9k
Qingding Wang United States 23 965 0.8× 148 0.5× 342 1.3× 143 0.6× 116 0.7× 45 1.6k

Countries citing papers authored by Neil A. Jones

Since Specialization
Citations

This map shows the geographic impact of Neil A. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil A. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil A. Jones more than expected).

Fields of papers citing papers by Neil A. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil A. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil A. Jones. The network helps show where Neil A. Jones may publish in the future.

Co-authorship network of co-authors of Neil A. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Neil A. Jones. A scholar is included among the top collaborators of Neil A. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil A. Jones. Neil A. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, John B., Steven M. Fox, Israel Gloger, et al.. (2008). The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone. Biomarkers. 13(6). 618–636. 41 indexed citations
2.
Jones, Neil A., et al.. (2006). Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro. Regulatory Peptides. 136(1-3). 109–116. 11 indexed citations
3.
Jones, Neil A.. (2004). Two-Dimensional Polyacrylamide Gel Electrophoresis for Proteome Analyses. Humana Press eBooks. 244. 353–360. 5 indexed citations
4.
Jones, Neil A., Victoria Boswell‐Smith, R. Lever, & Clive Page. (2004). The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro. Pulmonary Pharmacology & Therapeutics. 18(2). 93–101. 82 indexed citations
5.
Brown, Rachel A., Rebecca Lever, Neil A. Jones, & Clive Page. (2003). Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. British Journal of Pharmacology. 139(4). 845–853. 59 indexed citations
6.
Jones, Neil A. & Caroline Dive. (2003). Cell Sensitivity Assays: Detection of Apoptotic Cells In Vitro Using the TUNEL Assay. Humana Press eBooks. 28. 31–38. 1 indexed citations
7.
Jones, Neil A., Janet M. Allen, Annette M. Doherty, et al.. (2001). Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects. British Journal of Pharmacology. 133(5). 722–729. 34 indexed citations
8.
Woods, Angela, et al.. (2000). The regulation of AMP-activated protein kinase by phosphorylation. Biochemical Journal. 345(3). 437–437. 107 indexed citations
9.
Woods, Angela, et al.. (2000). The regulation of AMP-activated protein kinase by phosphorylation. Biochemical Journal. 345(3). 437–443. 493 indexed citations
10.
Griffiths, Gareth, Laurence Dubrez, Clive P. Morgan, et al.. (1999). Cell Damage-induced Conformational Changes of the Pro-Apoptotic Protein Bak In Vivo Precede the Onset of Apoptosis. The Journal of Cell Biology. 144(5). 903–914. 393 indexed citations
11.
12.
Vasey, P., Neil A. Jones, Suzanne Jenkins, Caroline Dive, & Robert Brown. (1996). Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.. Molecular Pharmacology. 50(6). 1536–1540. 96 indexed citations
13.
MacFarlane, Marion, Neil A. Jones, Caroline Dive, & Gerald M. Cohen. (1996). DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.. Molecular Pharmacology. 50(4). 900–911. 25 indexed citations
14.
Rowlands, D. C., et al.. (1995). The Proliferation-Associated Cytosolic Protein Lap18 (stathmin) is Expressed at Atypically Low Levels in BALB/c Plasmacytoma Cells. Current topics in microbiology and immunology. 194. 73–80. 3 indexed citations
15.
Rowlands, D. C., et al.. (1995). Stathmin is expressed by the proliferating hepatocytes during liver regeneration. Molecular Pathology. 48(2). M88–M92. 11 indexed citations
16.
17.
Jones, Neil A., D. C. Rowlands, William E. Johnson, I. C. M. Maclennan, & G. E. Brown. (1995). Persistent growth of BALB/C mouse plasmacytoma and human myeloma cell lines in the presence of phorbol myristate acetate is associated with continued expression of Lap18 (stathmin). Hematological Oncology. 13(1). 29–43. 3 indexed citations
18.
Rowlands, D. C., et al.. (1995). Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages.. PubMed. 72(1). 100–13. 50 indexed citations
19.
Jones, Neil A., Janet M. Lord, & G. E. Brown. (1992). Changes in the phosphorylation status of a 19 kD cytosolic protein are linked to the growth arrest of HL-60 cells. Leukemia Research. 16(4). 353–361. 8 indexed citations
20.
Lord, Janet M., Christopher M. Bunce, Philip J. French, et al.. (1991). Protein phosphorylation events and changes in inositol metabolism during HL60 cell differentiation. Biochemical Society Transactions. 19(2). 315–320. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prem M. Sharma Breakdown of academic impact, for papers by Winnie Eskild Breakdown of academic impact, for papers by Gabriel Gil‐Gómez Breakdown of academic impact, for papers by Chia-Chen Chen Breakdown of academic impact, for papers by Justina C. Wolters Breakdown of academic impact, for papers by Timothy Hadden Breakdown of academic impact, for papers by Seiji Inoshita Breakdown of academic impact, for papers by Lihong Chen Breakdown of academic impact, for papers by Yosuke Kawase Breakdown of academic impact, for papers by Qingding Wang
Rankless by CCL
2026